Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer.
Vanguri RS, Fenn KM, Kearney MR, Wang Q, Guo H, Marks DK, Chin C, Alcus CF, Thompson JB, Leu CS, Hibshoosh H, Kalinsky KM, Mathews JC, Nadeem S, Hollmann TJ, Connolly EP.
Vanguri RS, et al. Among authors: thompson jb.
Clin Breast Cancer. 2022 Aug;22(6):538-546. doi: 10.1016/j.clbc.2022.04.002. Epub 2022 Apr 18.
Clin Breast Cancer. 2022.
PMID: 35610143
Free PMC article.